David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVSA
1926
Covista Inc
CVSA
$4.69B
| $5.21M | ﹤0.01% |
137,767
-43,486
| -24% | -$1.61M |
|
|
CAS
1927
DELISTED
Cascade Acquisition Corp.
CAS
| $5.2M | ﹤0.01% |
522,811
+338,929
| +184% | +$3.35M |
|
1928
Standard BioTools
LAB
$256M
| $5.2M | ﹤0.01% |
789,207
+78,477
| +11% | +$516K |
|
|
MRTX
1929
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.2M | ﹤0.01% |
29,400
-20,000
| -40% | -$3.22M |
|
1930
Bio-Rad Laboratories Class A
BIO
$10.4B
| $5.17M | ﹤0.01% |
6,938
-6,246
| -47% | -$4.68M |
|
1931
CALL
General Dynamics
GD
$103B
| $5.17M | ﹤0.01% |
26,400
+16,400
| +164% | +$3.21M |
|
|
BIOT
1932
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $5.16M | ﹤0.01% |
529,830
+346,182
| +189% | +$3.36M |
|
1933
Beam Therapeutics
BEAM
$3.12B
| $5.16M | ﹤0.01% |
+59,243
| New | +$5.95M |
|
|
GWB
1934
DELISTED
Great Western Bancorp, Inc.
GWB
| $5.15M | ﹤0.01% |
157,324
+71,319
| +83% | +$2.2M |
|
|
EGRX
1935
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.14M | ﹤0.01% |
92,103
-32,865
| -26% | -$1.62M |
|
1936
CALL
Fidelity National Information Services
FIS
$21B
| $5.13M | ﹤0.01% |
+42,200
| New | +$5.66M |
|
|
SBNY
1937
DELISTED
Signature Bank
SBNY
| $5.13M | ﹤0.01% |
18,842
+15,463
| +458% | +$3.88M |
|
1938
Ubiquiti
UI
$36.1B
| $5.13M | ﹤0.01% |
17,164
+383
| +2% | +$118K |
|
1939
PUT
Martin Marietta Materials
MLM
$37.8B
| $5.13M | ﹤0.01% |
15,000
| – | – |
|
|
PPLI
1940
CALL
People Inc
PPLI
$2.92B
| $5.12M | ﹤0.01% |
47,907
| – | – |
|
|
ZGNX
1941
DELISTED
Zogenix, Inc.
ZGNX
| $5.12M | ﹤0.01% |
336,883
-375,701
| -53% | -$5.87M |
|
1942
Hanmi Financial
HAFC
$921M
| $5.12M | ﹤0.01% |
255,068
-8,329
| -3% | -$154K |
|
1943
LivaNova
LIVN
$4.41B
| $5.11M | ﹤0.01% |
64,576
+35,122
| +119% | +$2.89M |
|
1944
Brookfield
BN
$93B
| $5.1M | ﹤0.01% |
+176,922
| New | +$5.17M |
|
1945
Arcosa
ACA
$7.13B
| $5.09M | ﹤0.01% |
101,517
+9,741
| +11% | +$505K |
|
1946
CALL
Valero Energy
VLO
$100B
| $5.08M | ﹤0.01% |
72,000
| – | – |
|
|
PXD
1947
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.08M | ﹤0.01% |
30,500
+4,400
| +17% | +$666K |
|
1948
CALL
Dillards
DDS
$9.87B
| $5.07M | ﹤0.01% |
29,400
-1,200
| -4% | -$228K |
|
|
ACBI
1949
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $5.06M | ﹤0.01% |
191,047
-76,134
| -28% | -$1.86M |
|
1950
Banner Corp
BANR
$2.39B
| $5.06M | ﹤0.01% |
91,631
-6,859
| -7% | -$369K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.